TwitterLinkedin

Contact Us

  • News & Events
    • News
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Our Milestones
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical
          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Development Strategy and Gap Analysis
            • Integrated Product Development
            • Market Access
            • Non-clinical Development Concept
              and Study Design
            • Scientific Advice
            • Scientific Due Diligence
            • Statistical Services
            • Toxicology Services
    • Clinical Development
          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Orphan Drug Designation
            • Pediatric Investigation Plan (PIP)
            • Scientific Advice
            • Statistical Services
          • Regulatory Affairs

            • Clinical Trial Applications
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations
          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting
          • Quality

            • GxP Services
            • IMP Management
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
            • Vendor Management and Oversight
    • Authorization / Approval
          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistical Services
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting
          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance
          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Environmental Risk Assessment
            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services
          • Pharmacovigilance

            • Audit and CAPA Management
            • EU QPPV / National QPPV
            • ICSR Management
            • Literature Screening
            • Pharmacovigilance Systems
            • Safety Writing (PSUR, RMP)
            • Signal Management
          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • Good Distribution Practice (GDP) Compliance
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Vendor Audit
            • Vendor Management and Oversight
          • Medical Affairs

            • Healthcare Compliance and Medical Approval
            • Medical Information
    • Program Management
          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise
          • Industry Expertise

            • Biopharmaceuticals
            • Consulting
            • Consumer Healthcare
            • Generics
            • Herbal Medicines
            • Medicinal Products
            • MedTech Services
            • Pharmaceutical
            • Veterinary Drugs
          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • Brexit
            • COVID-19 Support
            • Drug Re-purposing / Value-added Medicines
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Statistical Services
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • News
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Career Opportunities
  • Training
Home > Our Services > CMC Services

CMC Services

Chemistry, Manufacturing and Controls (CMC)

CMC strategy and documentation plays an important role from early development to authoring of the marketing authorization application dossier. It also extends to change control and maintenance throughout the product lifecycle. Moreover, CMC requirements are complex and different for chemicals, biologicals, biosimilars, herbals or homeopathics. PharmaLex guides you to the best CMC approach for your products in line with health authority requirements and helps you to stay CMC compliant with sustainable processes.

Our CMC services include:

  • CMC content creation, compilation and maintenance support
  • CMC development biopharmaceuticals
  • CMC compliance

Want to find out more?

PharmaLex. Confidence beyond compliance.

Contact us for more information

CMC content creation, compilation and maintenance support

Our Chemistry, Manufacturing and Controls (CMC) team can provide you with regulatory strategy advice, scientific/technical writing and quality variation/amendment/supplement submission management on a global basis. We cover all CMC regulatory tasks from early development to authoring of the marketing authorization application dossier and beyond. We can give you regulatory guidance in dossier format, setting specifications, method development and validation documentation adapted to any type of medicinal product or drug substance/API and to any region worldwide. Whether it is a case of first-time submission, change control or maintenance throughout the product lifecycle, our multi-disciplinary team delivers CMC service that is aligned with the needs of your global submission management department, manufacturing sites and other stakeholders and that, of course, meets the latest Health Authority requirements.

Our services include:

  • Product scope includes human and veterinary medicinal products comprising all types of APIs (chemicals, biologicals, biosimilars, herbals and homeopathics)
  • Strategic consultancy during pharmaceutical development and lifecycle management
  • Regulatory CMC intelligence and data management
  • CMC scientific and technical writing
  • Compilation of quality dossiers (ICH and non-ICH)
    • CTD modules 3 and 2.3
    • IMPD, IND
    • ASMF / DMF, CEP
    • Normative document
  • CMC maintenance support: change control and quality variations
  • GxP services (GMP, GACP, GDP) including audits

CMC development biopharmaceuticals

Biopharmaceuticals are an unprecedented success story. Due to their outstanding efficacy and safety and their high potential to address unmet medical needs, biopharmaceuticals are by far the fastest-growing part of the industry and are already making up 20 percent of the global pharma market.

But the effort and amount of technological skills required for the development and production of these complex molecules are both challenging and evolving rapidly, and so are the associated expectations of the regulators. Therefore, it is essential to account for regulatory requirements early on in development and to carve out the most efficient path to approval to ensure commercial success.

Based on a broad global project experience, we at PharmaLex recommend an integrated solution combining our scientific, technological and regulatory expertise to meet your specific support needs, both for specific aspects or for the complete development process.

The product types we support include:

  • Recombinant proteins (e.g. mAbs (and derivatives), hormones, enzymes, fusion proteins)
  • Tissue, cell and gene therapy products / ATMPs
  • Biosimilars
  • (Non-recombinant) biologicals isolated from living sources
  • Peptides
  • Antibody drug conjugates (ADC)
  • Vaccines (recombinant proteins, live attenuates and recombinant vector vaccines)

Our services include:

  • Development and regulatory strategy considering regional requirements (e.g. US, EU, Canada, Japan, Emerging Markets)
  • Gap analysis / Due diligence
  • Scientific and technical writing and compilation of regulatory documents
  • Scientific advice and other Health Agency meetings
  • Risk assessment
  • Preparation of Target Product Profile (TPP)
  • Comparability exercises
  • General ‘troubleshooting’, including investigations and root cause analysis and support for CAPA
  • Deviation and change control preparation / review
  • Method / process validation
  • Process characterization
  • Project management

CMC Compliance

Chemistry Manufacturing and Controls (CMC) compliance is an important component in the lifecycle of a medicinal product, but is one that is continually challenged by many factors, including Merger and Acquisition (M&A) programs, increasingly complicated networks of internal and external manufacturing sites and insufficiently robust internal processes within an organization to manage complexity and cross-functional interfaces.

These factors often lead to compliance issues, which may have serious consequences from a delay in product approval requiring corrective actions up to product recalls and the loss of marketing authorizations. It is clear that the impact of non-compliances identified through Health Authority inspections can be extremely costly and can irrevocably damage a company’s reputation.

A strong partnership is required between the Regulatory and Quality functions with the necessary inputs to support the implementation of transformed systems and processes within an organization, which can ultimately provide a sustained CMC compliance outcome for a business.

Our team of CMC and Quality experts will help you make your compliance proactive and in line with Health Agencies’ requirements, supporting the uninterrupted supply of medicines to patients. Besides broad experience, we bring a standardized approach and ready-to-use templates for compliance gap analysis and remediation to the table. And we can provide the needed resources to manage such projects even under high time constraints.

Our services include:

  • CMC Due diligence (e.g. in-licensing activities) / Gap analysis
  • Product / patient impact assessment
  • Development and implementation of risk-based gap remediation plan
  • Root Cause Analysis of gaps in CMC information
  • Preparation for regulatory health authority inspection (incl. CAPA-management)
  • Optimization of the supply chain
25+ years of experience in global regulatory maintenance support and CMC
125+ CMC experts worldwide
750+ quality overall summary expert reports prepared
Proven track record with 7500 successfully completed projects

Related News

Supporting M&A in the pharmaceutical / biopharmaceutical industry
11th February 2021
webinar mergers acquisitions
Critical Considerations for Mergers & Acquisitions
8th February 2021
Annex 1
EU GMP Annex 1
25th January 2021

Related Resources

Fact Flyers

  • Regulatory Compliance - CMC Implementation
  • Biopharmaceuticals CMC
  • Chemistry, Manufacturing and Control (CMC)

Case Studies

  • Consultancy and eCTD submission support for master files
  • End of Phase-2 meeting
  • Regulatory CMC Compliance reduced risk
  • Global CMC responsibility during portfolio integration
  • Lifecycle management for drug products
  • Regulatory CMC compliance reduced workload by 20-25%
  • Due diligence for medicinal product documentation

White Papers

  • The Challenges of Achieving and Maintaining CMC Compliance
  • Together Beyond COVID-19 - A Look at the Future
  • Differing CMC requirements: US and EU

Webinars

  • Introduction to Bayesian Methodologies in CMC
  • Biotech Drug Development Challenges and Case Studies (CMC)
  • Achieving and maintaining REG CMC Compliance

Related Services

  • Biopharmaceuticals
  • Global End-to-End Outsourcing
  • Good Distribution Practice (GDP) Compliance
  • GxP Services
  • Integrated Product Development
  • Mergers and Acquisitions (M&A) Transfers

What our clients say

In these unprecedented times, PharmaLex continues to support all clients by meeting virtually and providing experienced, remote-based consultants.

PharmaLex Team Thomas
Thomas Dobmeyer, CEO PharmaLex
CEO PharmaLex

Hard working and there when you need them

Europe based large biotech
Regulatory Manager
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
Tweets by @PharmaLexGLOBAL
COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY
  • I just wanted to let you know that the recent EU Codes webinar was excellent. Rina presented a very complex and grey topic in the most clear and digestible manner – a sign of a true expert. The questions in the Q&A were sometimes a little ambiguous but Rina gave clear and relevant answers that provided real clarity.

    Richard Blackwell
    Medical Team Leader, Multi Tumor Franchise Roche Products Ltd
PharmaLex
©2021 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit Logo

#AskTheExpert #TogetherBEYONDCOVID19





    Select your state:

    .
    You can unsubscribe at any time at data.protection@pharmalex.com

    If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

    #TogetherBEYONDCOVID19

    We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for

      Please DO NOT send us event/conference information.
      We will not respond and these will be deleted immediately.





      Select your state:

      .
      You can unsubscribe at any time at
      data.protection@pharmalex.com

      If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

      Privacy Policy

      This can be specific information about signing up to the newsletter.

      Pellentesque lobortis, tellus at ultrices ullamcorper, lectus tellus consectetur lectus, id consequat leo quam quis eros. Mauris pellentesque tortor a augue pellentesque ultricies. Phasellus sit amet suscipit orci, vel dapibus ligula. Maecenas at pellentesque lectus, sit amet tristique felis. Integer fringilla risus ac neque mollis, at imperdiet lacus sodales. In vehicula orci sed vulputate interdum. Nunc sagittis non nunc eget sollicitudin.

      Maecenas a mattis erat. Phasellus cursus erat non nisl pulvinar ultricies. Aenean id fringilla libero. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Morbi in ultrices elit. Suspendisse egestas hendrerit est. Integer pellentesque nisl ut justo tempus, nec suscipit dolor luctus. Cras vestibulum elementum tincidunt.

      In compliance with the Spanish Law 15/1999, of Protection of Personal Data and in accordance with regulations approved by the Spanish RD 994/1999 inform you that your data will be part of a file located in Friedrichsdorf (Germany), whose ownership belongs to Pharmalex Spain S.L.U. The purpose of these data is the insertion in a potential job selection process. Inform the user that at any time may exercise their right of access, rectification, and deletion of data through email curriculum@pharmalex.com or to this postal address Pharmalex Spain. Coso 103, 50001 Zaragoza, Spain.